Atherosclerosis in Rheumatology: Old and New Insight
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F20%3A10420107" target="_blank" >RIV/00216208:11110/20:10420107 - isvavai.cz</a>
Alternative codes found
RIV/00023728:_____/20:N0000010
Result on the web
<a href="https://doi.org/10.5772/intechopen.88605" target="_blank" >https://doi.org/10.5772/intechopen.88605</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5772/intechopen.88605" target="_blank" >10.5772/intechopen.88605</a>
Alternative languages
Result language
angličtina
Original language name
Atherosclerosis in Rheumatology: Old and New Insight
Original language description
Cardiovascular diseases are the leading cause of morbidity and mortality in general population worldwide. There is an increasing significance of cardiovascular risk in the field of rheumatology, and accordingly, the evidence on the relation between immune system disorders and atherosclerosis has been substantially growing especially in last decades. Since novel immune and metabolic factors are considered to participate in pathogenesis of atherosclerosis and increased cardiovascular risk in rheumatic patients, they are getting to the forefront of the research. Since novel therapeutic approaches have improved survival of rheumatic patients, and decreased morbidity caused by rheumatic disease activity and damage, the significance of other comorbidities leading to premature mortality has arisen. Nevertheless, appropriate recommendations for the management of cardiovascular risk are still lacking. Recently, European League Against Rheumatism (EULAR) recommendations for management of the cardiovascular risk and comorbidities in patients with inflammatory arthropathies have been published. However, the cardiovascular management of these patients is still suboptimal. In addition, the situation in other orphan diseases such as idiopathic inflammatory myopathies, systemic sclerosis and others is even more uncertain and strongly requires further research. This chapter provides an overview of epidemiology, pathogenesis, clinical manifestations, screening and management of atherosclerosis in patients with rheumatic diseases.
Czech name
—
Czech description
—
Classification
Type
C - Chapter in a specialist book
CEP classification
—
OECD FORD branch
30226 - Rheumatology
Result continuities
Project
<a href="/en/project/NV18-01-00161" target="_blank" >NV18-01-00161: Atherosclerosis and cardiovascular risk in selected rheumatic diseases</a><br>
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Book/collection name
Atherosclerosis, Arteriosclerosis and Arteriolosclerosis
ISBN
978-1-83880-303-2
Number of pages of the result
24
Pages from-to
29-52
Number of pages of the book
71
Publisher name
IntechOpen
Place of publication
London
UT code for WoS chapter
—